Validation of dried blood spots for capturing hepatitis C virus diversity for genomic surveillance

  • Damien C. Tully
  • , Karen A. Power
  • , Jacklyn Sarette
  • , Thomas J. Stopka
  • , Peter D. Friedmann
  • , P. Todd Korthuis
  • , Hannah Cooper
  • , April M. Young
  • , David W. Seal
  • , Ryan P. Westergaard
  • , Todd M. Allen

Research output: Contribution to journalArticlepeer-review

3 Scopus citations

Abstract

Dried blood spots (DBS) have emerged as a promising alternative to traditional venous blood for hepatitis C virus (HCV) testing. However, their capacity to accurately reflect the genetic diversity of HCV remains poorly understood. We employed deep sequencing and advanced phylogenetic analyses on paired plasma and DBS samples from two common subtypes to evaluate the suitability of DBS for genomic surveillance. Results demonstrated that DBS captured equivalent viral diversity compared to plasma with no phylogenetic discordance observed. The ability of DBS to accurately reflect the profile of viral genetic diversity suggests it may be a promising avenue for future surveillance efforts to curb HCV outbreaks.

Original languageEnglish
Pages (from-to)266-270
Number of pages5
JournalJournal of Viral Hepatitis
Volume31
Issue number5
DOIs
StatePublished - May 2024

Bibliographical note

Publisher Copyright:
© 2024 John Wiley & Sons Ltd.

Funding

This work was supported by the National Institute of Drug Abuse (NIDA) grant U24DA044801. Data are based upon data collected and/or methods developed as part of the Rural Opioid Initiative (ROI), a multi‐site study with a common protocol developed collaboratively by investigators at eight research institutions and at the National Institute of Drug Abuse (NIDA), the Appalachian Regional Commission (ARC), the Centers for Disease Control and Prevention (CDC) and the Substance Abuse and Mental Health Services Administration (SAMHSA). Primary data collection was supported by grants UG3DA044798, UG3DA044830, UG3DA044831, UG3DA044826 co‐funded by NIDA, ARC, CDC and SAMHSA.

FundersFunder number
Automotive Research and Testing Center
Centers for Disease Control and Prevention
Substance Abuse and Mental Health Services Administration
Author National Institute on Drug Abuse DA031791 Mark J Ferris National Institute on Drug Abuse DA006634 Mark J Ferris National Institute on Alcohol Abuse and Alcoholism AA026117 Mark J Ferris National Institute on Alcohol Abuse and Alcoholism AA028162 Elizabeth G Pitts National Institute of General Medical Sciences GM102773 Elizabeth G Pitts Peter McManus Charitable Trust Mark J Ferris National Institute on Drug AbuseUG3DA044830, UG3DA044798, UG3DA044831, UG3DA044826, U24DA044801

    Keywords

    • DBS
    • HCV
    • genetic diversity
    • molecular epidemiology
    • phylogenetic

    ASJC Scopus subject areas

    • Hepatology
    • Virology
    • Infectious Diseases

    Fingerprint

    Dive into the research topics of 'Validation of dried blood spots for capturing hepatitis C virus diversity for genomic surveillance'. Together they form a unique fingerprint.

    Cite this